Keyphrases
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
15%
1-methyl-4-phenylpyridinium
7%
Active Center
7%
Antiangiogenic Activity
7%
Anticancer Agents
100%
Direct Inhibitors
100%
Direct Interaction
7%
Dopaminergic Neurons
7%
Endothelial Nitric Oxide Synthase (eNOS)
7%
Further Development
7%
Haem
7%
IC50 Value
7%
Induced Loss
7%
Inducible Nitric Oxide Synthase
7%
Molecular Docking
7%
MPP+
100%
Neurodegenerative Diseases
15%
Neuronal Apoptosis
7%
Neuronal NOS
100%
Neuroprotection
23%
Neuroprotective Action
7%
Neurotoxicity
100%
Non-competitive Inhibition
7%
NOS Activity
7%
NOS Isoforms
7%
Potent Inhibitor
7%
PTK787
7%
Reduced Expression
7%
Selective Inhibition
100%
Selective Inhibitor
7%
SU4312
100%
Swimming Behavior
7%
Tyrosine Hydroxylase
7%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
15%
Zebrafish
15%
Biochemistry, Genetics and Molecular Biology
Anticancer
100%
Docking (Molecular)
50%
Dopaminergic
50%
Endothelial NOS
50%
IC50
50%
Isoform
50%
Kinase Insert Domain Receptor
100%
Messenger RNA
50%
Neuroapoptosis
50%
Non-Competitive Inhibition
50%
Tyrosine Hydroxylase
50%
Vatalanib
100%
Zebra fish
100%
Pharmacology, Toxicology and Pharmaceutical Science
1 Methyl 4 Phenylpyridinium
25%
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
50%
Antiangiogenic
25%
Anticarcinogen
100%
Dopamine Receptor Stimulating Agent
25%
Heme
25%
IC50
25%
Malignant Neoplasm
25%
Messenger RNA
25%
Molecular Docking Simulations
25%
Neuroprotection
75%
Neuroprotective Agent
25%
Neurotoxicity
100%
Non-Competitive Inhibition
25%
Tyrosine 3 Monooxygenase
25%
Vasculotropin Receptor 2
50%
Vatalanib
50%
Zebra fish
50%
Neuroscience
Anticarcinogen
100%
Behavior (Neuroscience)
16%
Dopaminergic Neuron
16%
Heme
16%
In Vitro
33%
Kinase Insert Domain Receptor
33%
Messenger RNA
16%
Molecular Docking
16%
MPP+
100%
Neuroapoptosis
16%
Neurodegenerative Disorder
33%
Neuroprotection
50%
Neuroprotective Agent
16%
Neurotoxicity
100%
Non-Competitive Inhibition
16%
Tetrahydropyridine
33%
Tyrosine Hydroxylase
16%
Vatalanib
33%